An evaluation of current shigellosis treatment

Expert Opinion on Pharmacotherapy

Volumn 4, Issue 8, 2003, Pages 1315-1320

  Bhattacharya, Sujit Kumar ^a   Sur, Dipika ^a  

^a NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

Author keywords

Antibiotics; Drug resistance; Epidemics; Shigella; Shigellosis; Therapy

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIAMEBIC AGENT; ATROPINE PLUS DIPHENOXYLATE; AZITHROMYCIN; BICARBONATE; BISMUTH SALICYLATE; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CITRATE TRISODIUM; COTRIMOXAZOLE; FURAZOLIDONE; GLUCOSE DERIVATIVE; KAOLIN PECTIN; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; OPIATE; ORAL REHYDRATION SOLUTION; PAREGORIC; PIVMECILLINAM; POTASSIUM CHLORIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SHIGELLA VACCINE; SODIUM CHLORIDE; SULFONAMIDE; TETRACYCLINE; UNINDEXED DRUG;

ANOREXIA; ANTIBIOTIC SENSITIVITY; DEHYDRATION; DIARRHEA; DISEASE TRANSMISSION; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG TOLERABILITY; HAND WASHING; HEMOLYTIC UREMIC SYNDROME; HUMAN; LEUKEMOID REACTION; MULTIDRUG RESISTANCE; NAUSEA AND VOMITING; ORAL REHYDRATION THERAPY; REVIEW; SEROTYPE; SHIGELLA BOYDII; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI; SHIGELLA SONNEI; SHIGELLOSIS; SINGLE DRUG DOSE;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CHILD; DYSENTERY, BACILLARY; EATING; FLUID THERAPY; HUMANS;

EID: 0041633593     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.4.8.1315     Document Type: Review

References (36)

1. Weekly Epidemiological Record Vaccine Research and Development. New Strategies for accelerating Shigella vaccine development. World Health Organization, Geneva, 14 March. (1997) 73-80.
2. MATA LJ, GANGAROSA EJ, CACERAS A et al.: Epidemic Shiga bacillus dysentery in Central America. Etiologic investigations in Guatemala, 1969. J. Infect. Dis. (1970) 122:170-180.
3. MUTANDA LN, KAVITA JN, WAMOLA IA: Patterns of Shigella species and serotypes in East Africa. East Afr. Med. J. (1979) 56:381-387.
4. RAHAMAN MM, KHAN MM, AZIZ KMS et al.: An outbreak of dysentery caused by Shigella dysenteriae type 1 on a coral island in the Bay of Bengal. J. Infect. Dis. (1975) 132:15-19.
5. KHAN M, SHAHIDULLAH M: Contrasting epidemiology of Shigella dysenteriae and Shigella flexneri, Dacca. Trans. R. Soc. Trop. Med. Hyg. (1980) 74:528-533.
6. KHAN M, CURLIN GT, HUQ I: Epidemiology of Shigella dysenteriae type 1 infections in Dacca urban area. Trop. Geogr. Med. (1979) 31:213-223.
7. STOLL BG, GLASS RI, HUQ MI et al.: Epidemiological and clinical features of patients infected with Shigella who attended a diarrhoeal disease hospital in Bangladesh. J. Infect. Dis. (1982) 146:177-183.
8. MATHAN VI, BHAT P, KAPADIA CR et al.: Epidemia dysentery caused by the Shiga bacillus in a Southern Indian village. J. Diarrhoeal Dis. Res. (1984) 2:27-32.
9. VELAUTHAPILLAI K: Epidemiology and bacteriology of Shigella shiga dysentery. Sri Lankan Family Physician (1980) 5:98.
10. SONNADARA DA: Shigella shiga dysentery in children. Sri Lankan Family Physician (1982) 5:110.
11. REZVI SHERIFF MH: Lessons to learn from my Maldivian experience with the Shigella dysentery. Sri Lankan Family Physician (1982) 5:117.
12. PAL SC: Epidemic bacillary dysentery in West Bengal. Lancet (1984) 1:1462.
13. BOSE R, NASHIPURI JN, SEN PK et al.: Epidemic of dysentery in West Bengal: clinicians' enigma. Lancet (1984) 2:1160.
14. SEN D, SENGUPTA PG, BHATTACHARYA SK et al.: Epidemic Shiga bacillus dysentery in Port Blair, Andaman and Nicobar Islands, India. J. Diarr. Dis. Res. (1986) 4:161.
15. BARRETT CONNOR E, CONNOR JD: Extraintestinal manifestations of shigellosis. Am. J. Gastroenterol. (1970) 53:234-245.
16. BHATTACHARYA SK, SINHA AK, SEN D et al.: Extraintestinal manifestations of Shigellosis during an epidemic of bacillary dysentery in Port Blair, Andaman & Nicobar Islands (India). J. Assoc. Physicians India (1988) 36(5):319-320.
17. RAHAMAN MM, ALAM AKMJ, ISLAM MR: Leukaemoid reaction, haemolytic anaemia and hyponatraemia in severe Shigella dysenteriae type 1 infection. Lancet (1974) 1:1004 (Letter).
18. NELSON JD, KUSMIESZ H, JACKSON LH: Comparison of trimethoprim/sulfamethoxazole and ampicillin therapy for shigellosis in ambulatory patients. J. Pediatr. (1976) 89:491.
19. ROSS S, CONTRONI G, KHAN W: Resistance of shigellae to ampicillin and other antibiotic. J. Am. Med. Assoc. (1972) 221:45.
20. SEN D, DUTTA P, DEB BC, PAL SC: Nalidixic acid resistant Shigella dysenteriae type 1 in eastern India. Lancet (1988) 2:911.
21. BHATTACHARYA SK, BHATTACHARYA MK, DUTTA P et al.: Randomized clinical trial of norfloxacin for shigellosis. J. Trop. Med. Hyg. (1991) 445:683-687.
22. BENNIS ML, SALAM MA, HAIDER R, BARZA M: Therapy for shigellosis. II. Randomized, double-blind comparison of ciprofloxacin and ampicillin. J. Infect. Dis. (1990) 162:711-716.
23. NIYOGI SK, MITRA U, DUTTA P: Changing pattern of serotypes and antimicrobial susceptibility of Shigella species isolated from children in Calcutta, India. Jpn J. Infect. Dis. (2001) 54:121-122.
24. SUR D, NIYOGI SK, SUR S et al.: Multidrug-resistant Shigella dysenteriae type 1: forerunners of a new epidemic strain in eastern India? Emerg. Infect. Dis. (2003) 9(3):404-405.
25. SARKAR K, GHOSH S, NIYOGI SK et al.: Shigella dysenteriae type 1 with reduced susceptibility to fluoroquinolones. Lancet (2003) 361:9359.
26. GASSAMA A, SOW PS, FALL F et al.: Ordinary and opportunistic enteropathogens associated with diarrhea in Senegalese adults in relation to human immunodeficiency virus serostatus. Int. J. Infect. Dis. (2001) 5(4):192-198.
27. CHANG MJ, DUNKLE LM, VAN RD et al.: Trimethoprim-sulfamethoxazole compared to ampicillin in the treatment of shigellosis. Paediatrics (1977) 59:726.
28. GOTUZZO E, OBERHELMAN RA, MAGUINA C et al.: Comparison of single dose treatment with norfloxacin and standard 5 day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults. Antimicrob. Agents Chemother. (1989) 33(7):1101-1104.
29. BHATTACHARYA SK, BHATTACHARYA MK, DUTTA D et al.: Single-dose ciprofloxacin for shigellosis in adults. J. Infect. (1992) 25(1):117-119.
30. BENNIS ML, SALAM MA, KHAN WA et al.: Treatment of shigellosis, III. Randomized blinded comparison of one or two dose ciprofloxacin and standard 5 day therapy. Annals Inter Med. (1992) 19:695-698.
31. BHATTACHARYA SK, BHATTACHARYA MK, DUTTA D et al.: Double blind, randomized clinical trial for safety and efficacy of norfloxacin for shigellosis in children. Acta Paediatr. (1997) 86:319-320.
32. KABIR I, RAHMAN MM, AHMED SM, AKTHER SQ, BUTLER T: Comparative efficacies of pivmecillinam and ampicillin in acute shigellosis. Antimicrob. Agents Chemother. (1984) 25(5):643-645.
33. BASUALDO W, ARBO A: Randomized comparison of azithromycin versus cefixime for treatment of shigellosis in children. Pediatr. Infect. Dis. J. (2003) 22(4):347-347.
34. KHAN WA, SEAS C, DHAR U, SALAM MA, BENNISH ML: Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial. Ann. Intern. Med. (1997) 126(9):697-703.
35. The treatment of diarrhoea. A manual for physicians and other senior health workers. WHO, Geneva, Switzerland (1995) (WHO/CDR/95.3).
36. DUPONT HL, HORNICK RB: Adverse effect of lomotil therapy in shigellosis. J. Am. Med. Assoc. (1973) 225:1525.